Management of NSCLC: The Era of Immunotherapy
Kanker paru merupakan jenis kanker yang paling sering didiagnosis dan merupakan penyebab utama kematian terkait kanker di seluruh dunia. Data GLOBOCAN menyebutkan bahwa kanker paru menyumbang sekitar 13% dari diagnosis kanker pada 2012, dan diperkirakan 1,8 juta kasus kanker paru baru yang didiagnos...
Saved in:
Main Author: | Laksmi Wulandari, - |
---|---|
Format: | Book Section PeerReviewed |
Language: | English English |
Published: |
Universitas Negeri Solo
2019
|
Subjects: | |
Online Access: | https://repository.unair.ac.id/118357/1/Artikel.pdf https://repository.unair.ac.id/118357/2/Peer%20Review.pdf https://repository.unair.ac.id/118357/ |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Universitas Airlangga |
Language: | English English |
Similar Items
-
Treatment Strategies in ALK-Positive NSCLC
by: Laksmi Wulandari, -
Published: (2019) -
Clinical Benefit of EGFR-TKI in Management of NSCLC
by: Siprianus Ugroseno Yudho Bintoro
Published: (2017) -
Response Evaluation on Single Common and Uncommon EGFR Mutation on First-Generation EGFR-TKI Therapy in NSCLC Patients
by: Rena Arusita Maranatha, et al.
Published: (2021) -
Comparison between Vinorelbine–Carboplatin and Vinorelbine–Cisplatin in Stage III–IV EGFR Mutations-Negative NSCLC
by: Laksmi Wulandari, -, et al.
Published: (2022) -
The Role and Benefit of Pemetrexeed in The First Line Treatment of NSCLC
by: Siprianus Ugroseno Yudho Bintoro
Published: (2017)